• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MDM2和MDMX对肿瘤抑制因子p53和RB的双重作用。

Dual function of MDM2 and MDMX toward the tumor suppressors p53 and RB.

作者信息

Hernández-Monge Jesús, Rousset-Roman Adriana Berenice, Medina-Medina Ixaura, Olivares-Illana Vanesa

机构信息

Instituto de Física, Universidad Autónoma de San Luis Potosí, Av Manuel Nava No 6 Zona Universitaria CP 78290. SLP, México.

出版信息

Genes Cancer. 2016 Sep;7(9-10):278-287. doi: 10.18632/genesandcancer.120.

DOI:10.18632/genesandcancer.120
PMID:28050229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5115168/
Abstract

The orchestrated crosstalk between the retinoblastoma (RB) and p53 pathways contributes to preserving proper homeostasis within the cell. The deregulation of one or both pathways is a common factor in the development of most types of human cancer. The proto-oncoproteins MDMX and MDM2 are the main regulators of the well- known tumor suppressor p53 protein. Under normal conditions, MDM2 and MDMX inhibit p53, either via repression of its transcriptional activity by protein-protein interaction, or via polyubiquitination as a result of MDM2-E3 ubiquitin ligase activity, for which MDM2 needs to dimerize with MDMX. Under genotoxic stress conditions, both become positive regulators of p53. The ATM-dependent phosphorylation of MDM2 and MDMX allow them to bind mRNA, these interactions promote p53 translation. MDM2 and MDMX are also being revealed as effective regulators of the RB protein. MDM2 is able to degrade RB by two different mechanisms, that is, by ubiquitin dependent and independent pathways. MDMX enhances the ability of MDM2 to bind and degrade RB protein. However, MDMX also seems to stabilize RB through interaction and competition with MDM2. Here, we will contextualize the findings that suggest that the MDM2 and MDMX proteins have a dual function on both p53 and RB.

摘要

视网膜母细胞瘤(RB)通路与p53通路之间精心编排的相互作用有助于维持细胞内适当的稳态。一条或两条通路的失调是大多数类型人类癌症发生发展的共同因素。原癌蛋白MDMX和MDM2是著名的肿瘤抑制蛋白p53的主要调节因子。在正常情况下,MDM2和MDMX通过蛋白质-蛋白质相互作用抑制p53的转录活性,或通过MDM2-E3泛素连接酶活性导致的多聚泛素化来抑制p53,而MDM2需要与MDMX二聚化才能发挥此作用。在基因毒性应激条件下,二者都成为p53的正向调节因子。MDM2和MDMX的ATM依赖性磷酸化使其能够结合mRNA,这些相互作用促进p53的翻译。MDM2和MDMX也被发现是RB蛋白的有效调节因子。MDM2能够通过两种不同机制降解RB,即通过泛素依赖性和非依赖性途径。MDMX增强MDM2结合和降解RB蛋白的能力。然而,MDMX似乎也通过与MDM2的相互作用和竞争来稳定RB。在此,我们将阐述一些研究结果,这些结果表明MDM2和MDMX蛋白对p53和RB都具有双重功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92d2/5115168/50f987672607/ganc-07-278-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92d2/5115168/953c3cc60fd6/ganc-07-278-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92d2/5115168/2c63d37f3827/ganc-07-278-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92d2/5115168/50f987672607/ganc-07-278-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92d2/5115168/953c3cc60fd6/ganc-07-278-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92d2/5115168/2c63d37f3827/ganc-07-278-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92d2/5115168/50f987672607/ganc-07-278-g003.jpg

相似文献

1
Dual function of MDM2 and MDMX toward the tumor suppressors p53 and RB.MDM2和MDMX对肿瘤抑制因子p53和RB的双重作用。
Genes Cancer. 2016 Sep;7(9-10):278-287. doi: 10.18632/genesandcancer.120.
2
MDMX exerts its oncogenic activity via suppression of retinoblastoma protein.MDMX 通过抑制视网膜母细胞瘤蛋白发挥致癌活性。
Oncogene. 2015 Oct 29;34(44):5560-9. doi: 10.1038/onc.2015.11. Epub 2015 Feb 23.
3
ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation.ATM介导的磷酸化作用通过HAUSP抑制Mdmx/Mdm2的稳定性,从而有利于p53的激活。
Cell Cycle. 2005 Sep;4(9):1166-70. doi: 10.4161/cc.4.9.1981. Epub 2005 Sep 29.
4
MDM2/MDMX: Master negative regulators for p53 and RB.MDM2/MDMX:p53和RB的主要负调控因子。
Mol Cell Oncol. 2016 Feb 18;3(2):e1106635. doi: 10.1080/23723556.2015.1106635. eCollection 2016 Mar.
5
Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.Mdm2和MdmX融合蛋白的过表达会改变p53介导的反式激活、泛素化及降解过程。
Biochemistry. 2003 Mar 4;42(8):2291-9. doi: 10.1021/bi0271291.
6
ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.DNA损伤后,ATM和Chk2依赖的MDMX磷酸化有助于p53激活。
EMBO J. 2005 Oct 5;24(19):3411-22. doi: 10.1038/sj.emboj.7600812. Epub 2005 Sep 15.
7
Mouse modelling of the MDM2/MDMX-p53 signalling axis.MDM2/MDMX-p53信号轴的小鼠模型
J Mol Cell Biol. 2017 Feb 1;9(1):34-44. doi: 10.1093/jmcb/mjx006.
8
MDMX under stress: the MDMX-MDM2 complex as stress signals hub.应激状态下的MDMX:作为应激信号枢纽的MDMX-MDM2复合物
Transl Cancer Res. 2016 Dec;5(6):725-732. doi: 10.21037/tcr.2016.12.18.
9
A site-directed mutagenesis study of the MdmX RING domain.MdmX RING 结构域的定点突变研究。
Biochem Biophys Res Commun. 2014 May 16;447(4):696-701. doi: 10.1016/j.bbrc.2014.04.065. Epub 2014 Apr 19.
10
FL118 induces p53-dependent senescence in colorectal cancer cells by promoting degradation of MdmX.FL118通过促进MdmX的降解在结肠癌细胞中诱导p53依赖性衰老。
Cancer Res. 2014 Dec 15;74(24):7487-97. doi: 10.1158/0008-5472.CAN-14-0683.

引用本文的文献

1
Analysis of pathogenic variants in retinoblastoma reveals a potential gain of function mutation.视网膜母细胞瘤致病变异分析揭示了一个潜在的功能获得性突变。
Genes Cancer. 2025 Jan 20;16:1-15. doi: 10.18632/genesandcancer.239. eCollection 2025.
2
Bioinformatics analysis proposes a possible role for long noncoding RNA MIR17HG in retinoblastoma.生物信息学分析提出长非编码 RNA MIR17HG 在视网膜母细胞瘤中可能发挥作用。
Cancer Rep (Hoboken). 2024 Feb;7(2):e1933. doi: 10.1002/cnr2.1933. Epub 2024 Feb 6.
3
Inhibition of adenovirus transport from the endosome to the cell nucleus by rotenone.

本文引用的文献

1
MDM2/MDMX: Master negative regulators for p53 and RB.MDM2/MDMX:p53和RB的主要负调控因子。
Mol Cell Oncol. 2016 Feb 18;3(2):e1106635. doi: 10.1080/23723556.2015.1106635. eCollection 2016 Mar.
2
Allosteric Interactions by p53 mRNA Govern HDM2 E3 Ubiquitin Ligase Specificity under Different Conditions.p53信使核糖核酸的变构相互作用在不同条件下调控HDM2 E3泛素连接酶的特异性。
Mol Cell Biol. 2016 Jul 29;36(16):2195-205. doi: 10.1128/MCB.00113-16. Print 2016 Aug 15.
3
Secondary interaction between MDMX and p53 core domain inhibits p53 DNA binding.
鱼藤酮对腺病毒从内体转运至细胞核的抑制作用。
Front Pharmacol. 2024 Jan 11;14:1293296. doi: 10.3389/fphar.2023.1293296. eCollection 2023.
4
State of the Art of Pharmacological Activators of p53 in Ocular Malignancies.眼部恶性肿瘤中p53药理激活剂的研究现状
Cancers (Basel). 2023 Jul 12;15(14):3593. doi: 10.3390/cancers15143593.
5
Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug.丹参酮IIA与肝细胞癌:一种潜在的治疗药物。
Front Oncol. 2023 Jan 31;13:1071415. doi: 10.3389/fonc.2023.1071415. eCollection 2023.
6
Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer.靶向DNA损伤反应和DNA修复途径以增强结直肠癌的放射敏感性
Cancers (Basel). 2022 Oct 5;14(19):4874. doi: 10.3390/cancers14194874.
7
Molecular Mechanism of Tanshinone against Prostate Cancer.丹参酮防治前列腺癌的分子机制。
Molecules. 2022 Aug 30;27(17):5594. doi: 10.3390/molecules27175594.
8
Epigenetic Silencing of and Epi-Transcriptional Silencing of Underlied Progression to Secondary Acute Myeloid Leukemia in Myelodysplastic Syndrome Treated with Hypomethylating Agents.表观遗传沉默的 和 Epi-转录沉默的 MDS 患者经低甲基化剂治疗后进展为继发性急性髓系白血病的基础。
Int J Mol Sci. 2022 May 18;23(10):5670. doi: 10.3390/ijms23105670.
9
Hinokiflavone Inhibits MDM2 Activity by Targeting the MDM2-MDMX RING Domain.双氢黄酮醇通过靶向 MDM2-MDMX RING 结构域抑制 MDM2 活性。
Biomolecules. 2022 Apr 27;12(5):643. doi: 10.3390/biom12050643.
10
Identification of Epigenetically Modified Hub Genes and Altered Pathways Associated With Retinoblastoma.与视网膜母细胞瘤相关的表观遗传修饰关键基因及改变通路的鉴定
Front Cell Dev Biol. 2022 Mar 10;10:743224. doi: 10.3389/fcell.2022.743224. eCollection 2022.
MDMX与p53核心结构域之间的二级相互作用抑制p53与DNA的结合。
Proc Natl Acad Sci U S A. 2016 May 10;113(19):E2558-63. doi: 10.1073/pnas.1603838113. Epub 2016 Apr 25.
4
MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data.恶性胸膜间皮瘤不同组织学亚型中MDM2和HIF1α的表达水平:与病理及临床数据的相关性
Oncotarget. 2015 Dec 8;6(39):42053-66. doi: 10.18632/oncotarget.5974.
5
A Novel Retinoblastoma Protein (RB) E3 Ubiquitin Ligase (NRBE3) Promotes RB Degradation and Is Transcriptionally Regulated by E2F1 Transcription Factor.一种新型视网膜母细胞瘤蛋白(RB)E3泛素连接酶(NRBE3)促进RB降解,并受E2F1转录因子的转录调控。
J Biol Chem. 2015 Nov 20;290(47):28200-28213. doi: 10.1074/jbc.M115.655597. Epub 2015 Oct 6.
6
Critical review about MDM2 in cancer: Possible role in malignant mesothelioma and implications for treatment.关于MDM2在癌症中的批判性综述:在恶性间皮瘤中的可能作用及对治疗的影响
Crit Rev Oncol Hematol. 2016 Jan;97:220-30. doi: 10.1016/j.critrevonc.2015.08.019. Epub 2015 Aug 22.
7
Regulation of the retinoblastoma-E2F pathway by the ubiquitin-proteasome system.泛素-蛋白酶体系统对视网膜母细胞瘤-E2F 通路的调控。
Biochim Biophys Acta. 2015 Oct;1849(10):1289-97. doi: 10.1016/j.bbagrm.2015.08.008. Epub 2015 Aug 28.
8
Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo.p53和RB功能通路的同时失活预示着乳腺癌在体内对DNA损伤药物具有抗性。
Mol Oncol. 2015 Oct;9(8):1553-64. doi: 10.1016/j.molonc.2015.04.008. Epub 2015 May 8.
9
MDMX exerts its oncogenic activity via suppression of retinoblastoma protein.MDMX 通过抑制视网膜母细胞瘤蛋白发挥致癌活性。
Oncogene. 2015 Oct 29;34(44):5560-9. doi: 10.1038/onc.2015.11. Epub 2015 Feb 23.
10
RB loss contributes to aggressive tumor phenotypes in MYC-driven triple negative breast cancer.RB缺失促成了MYC驱动的三阴性乳腺癌中的侵袭性肿瘤表型。
Cell Cycle. 2015;14(1):109-22. doi: 10.4161/15384101.2014.967118.